Abeona Therapeutics to Host R&D Day on December 6, 2018
November 29 2018 - 8:45AM
Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage
biopharmaceutical company focused on developing novel cell and gene
therapies for life-threatening rare genetic diseases, today
announced it will host its 2nd R&D Day event for the
institutional investment community in New York on Thursday,
December 6, 2018. The formal program is scheduled to begin at 8:45
am ET and conclude at 1:00 pm ET. A live webcast of the event will
be available on the investor relations section of Company’s website
at www.abeonatherapeutics.com. The program will include
presentations and panel discussions featuring senior management,
clinical investigators and key opinion leaders on current topics in
gene therapy.
About AbeonaAbeona Therapeutics
Inc. is a clinical-stage biopharmaceutical company developing cell
and gene therapies for life-threatening rare genetic diseases.
Abeona's lead programs include EB-101 (gene-corrected skin grafts)
for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102
(AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for
Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV-NAGLU), an
adeno-associated virus (AAV) based gene therapy for Sanfilippo
syndrome type B (MPS IIIB). Abeona is also developing ABO-201
(AAV-CLN3) gene therapy for CLN3 disease, ABO-202 (AAV-CLN1) for
treatment of CLN1 disease, EB-201 for epidermolysis bullosa (EB),
ABO-301 (AAV-FANCC) for Fanconi anemia (FA) disorder and ABO-302
using a novel CRISPR/Cas9-based gene editing approach to gene
therapy for rare blood diseases. In addition, Abeona is developing
a proprietary vector platform, AIM™, for next generation product
candidates. For more information, visit
www.abeonatherapeutics.com.
Investor Contact:Christine Silverstein SVP,
Finance & Investor Relations Abeona Therapeutics Inc. +1 (646)
813-4707 csilverstein@abeonatherapeutics.com
Media Contact:Scott Santiamo Director,
Corporate Communications Abeona Therapeutics Inc. +1 (718) 344-5843
ssantiamo@abeonatherapeutics.com
Abeona Therapeutics (NASDAQ:ABEO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Abeona Therapeutics (NASDAQ:ABEO)
Historical Stock Chart
From Sep 2023 to Sep 2024